Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 24 results.
User Information
Export Records
  1. 1.   SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
  2. Joyce, M. Gordon; Chen, Wei-Hung; Sankhala, Rajeshwer S.; Hajduczki, Agnes; Thomas, Paul; Choe, Misook; Martinez, Elizabeth J.; Chang, William C.; Peterson, Caroline E.; Morrison, Elaine B.; Smith,Clayton; Chen, Rita E.; Ahmed, Aslaa; Wieczorek, Lindsay; Anderson, Alexander; Case, James Brett; Li, Yifan; Oertel, Therese; Rosado, Lorean; Ganesh, Akshaya; Whalen, Connor; Carmen, Joshua M.; Mendez-Rivera, Letzibeth; Karch, Christopher P.; Gohain, Neelakshi; Villar, Zuzana; McCurdy, David; Beck, Zoltan; Kim, Jiae; Shrivastava, Shikha; Jobe, Ousman; Dussupt, Vincent; Molnar, Sebastian; Tran, Ursula; Kannadka, Chandrika B.; Soman, Sandrine; Kuklis, Caitlin; Zemil, Michelle; Khanh, Htet; Wu,Weimin; Cole, Matthew A.; Duso, Debra K.; Kummer, Larry W.; Lang, Tricia J.; Muncil, Shania E.; Currier, Jeffrey R.; Krebs, Shelly J.; Polonis, Victoria R.; Rajan, Saravanan; McTamney, Patrick M.; Esser, Mark T.; Reiley, William W.; Rolland, Morgane; de Val, Natalia; Diamond, Michael S.; Gromowski, Gregory D.; Matyas, Gary R.; Rao, Mangala; Michael, Nelson L.; Modjarrad, Kayvon
  3. CELL REPORTS. 2021, DEC 21; 37(12):
  1. 2.   Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge
  2. Felber,Barbara; Lu, Zhongyan; Hu, Xintao; Valentin,Antonio; Rosati,Margherita; Remmel, Christopher A L; Weiner, Joshua A; Carpenter, Margaret C; Faircloth, Katelyn; Stanfield-Oakley, Sherry; Williams, Wilton B; Shen, Xiaoying; Tomaras, Georgia D; LaBranche, Celia C; Montefiori, David; Trinh, Hung V; Rao, Mangala; Alam, Munir S; Vandergrift, Nathan A; Saunders, Kevin O; Wang, Yunfei; Rountree, Wes; Das, Jishnu; Alter, Galit; Reed, Steven G; Aye, Pyone P; Schiro, Faith; Pahar, Bapi; Dufour, Jason P; Veazey, Ronald S; Marx, Preston A; Venzon, David J; Shaw, George M; Ferrari, Guido; Ackerman, Margaret E; Haynes, Barton F; Pavlakis,George
  3. Cell reports. 2020, May 12; 31(6): 107624.
  1. 3.   SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses
  2. Lai, L. L.; Kwa, S. F.; Kozlowski, P. A.; Montefiori, D. C.; Nolen, T. L.; Hudgens, M. G.; Johnson, W. E.; Ferrari, G.; Hirsch, V. M.; Felber, B. K.; Pavlakis, G. N.; Earl, P. L.; Moss, B.; Amara, R. R.; Robinson, H. L.
  3. Vaccine. 2012, Feb; 30(9): 1737-1745.
  1. 4.   Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections
  2. Gnanakaran, S.; Bhattacharya, T.; Daniels, M.; Keele, B. F.; Hraber, P. T.; Lapedes, A. S.; Shen, T. Y.; Gaschen, B.; Krishnamoorthy, M.; Li, H.; Decker, J. M.; Salazar-Gonzalez, J. F.; Wang, S. Y.; Jiang, C. L.; Gao, F.; Swanstrom, R.; Anderson, J. A.; Ping, L. H.; Cohen, M. S.; Markowitz, M.; Goepfert, P. A.; Saag, M. S.; Eron, J. J.; Hicks, C. B.; Blattner, W. A.; Tomaras, G. D.; Asmal, M.; Letvin, N. L.; Gilbert, P. B.; DeCamp, A. C.; Magaret, C. A.; Schief, W. R.; Ban, Y. E. A.; Zhang, M.; Soderberg, K. A.; Sodroski, J. G.; Haynes, B. F.; Shaw, G. M.; Hahn, B. H.; Korber, B.
  3. Plos Pathogens. 2011, Sep; 7(9): 19.
  1. 5.   Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals
  2. Ho, J.; Moir, S.; Wang, W.; Posada, J. G.; Gu, W. J.; Rehman, M. T.; Dewar, R.; Kovacs, C.; Sneller, M. C.; Chun, T. W.; Follmann, D. A.; Fauci, A. S.
  3. Aids. 2011, Jan; 25(3): 295-302.
  1. 6.   A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation
  2. Vagenas, P.; Aravantinou, M.; Williams, V. G.; Jasny, E.; Piatak, M.; Lifson, J. D.; Salazar, A. M.; Blanchard, J. L.; Gettie, A.; Robbiani, M.
  3. Plos One. 2010, Sep; 5(9): 13.
  1. 7.   FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
  2. Klinman, D. M.; Klaschik, S.; Tross, D.; Shirota, H.; Steinhagen, F.
  3. Vaccine. 2010, Apr; 28(16): 2801-2805.
  1. 8.   Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239
  2. Vagenas, P.; Williams, V. G.; Piatak, M.; Bess, J. W.; Lifson, J. D.; Blanchard, J. L.; Gettie, A.; Robbiani, M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009 52(4): 433-442.
  1. 9.   Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV89.6P challenge in rhesus macaques
  2. Chong, S. Y.; Egan, M. A.; Kutzler, M. A.; Megati, S.; Masood, A.; Roopchard, V.; Garcia-H, D.; Montefiori, D. C.; Quiroz, J.; Rosati, M.; Schadeck, E. B.; Boyer, J. D.; Pavlakis, G. N.; Weiner, D. B.; Sidhu, M.; Eldridge, J. H.; Israel, Z. R.
  3. Vaccine. 2007, Jun; 25(26): 4967-4982.
  1. 10.   Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques
  2. Luckay, A.; Sidhu, M. K.; Kjeken, R.; Megati, S.; Chong, S. Y.; Roopch, V.; Garcia-H, D.; Abdullah, R.; Braun, R.; Montefiori, D. C.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.; Mathiesen, I.; Israel, Z. R.; Eldridge, J. H.; Egan, M. A.
  3. Journal of Virology. 2007, May; 81(10): 5257-5269.
  1. 11.   DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
  2. Rosati, M.; von Gegerfelt, A.; Roth, P.; Alicea, C.; Valentin, A.; Robert-Guroff, M.; Venzon, D.; Montefiori, D. C.; Markham, P.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Virology. 2005, JUL; 79(13): 8480-8492.
  1. 12.   Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen
  2. Neelapu, S. S.; Baskar, S.; Gause, B. L.; Kobrin, C. B.; Watson, T. M.; Frye, A. R.; Pennington, R.; Harvey, L.; Jaffe, E. S.; Robb, R. J.; Popescu, M. C.; Kwak, L. W.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8309-8317.
  1. 13.   Insufficient production and tissue delivery of CD4(+) memory T cells in rapidly progressive simian immunodeficiency virus infection
  2. Picker, L. J.; Hagen, S. I.; Lum, R.; Reed-Inderbitzin, E. F.; Daly, L. M.; Sylwester, A. W.; Walker, J. M.; Siess, D. C.; Piatak, M.; Wang, C. X.; Allison, D. B.; Maino, V. C.; Lifson, J. D.; Kodama, T.; Axthelm, M. K.
  3. Journal of Experimental Medicine. 2004, NOV 15; 200(10): 1299-1314.
  1. 14.   Macaque dendritic cells infected with SIV-recombinant canarypox ex vivo induce SIV-specific immune responses in vivo
  2. Villamide-Herrera, L.; Ignatius, R.; Eller, M. A.; Wilkinson, K.; Griffin, C.; Mehlhop, E.; Jones, J.; Han, S. Y.; Lewis, M. G.; Parrish, S.; Vancott, T. C.; Lifson, J. D.; Schlesinger, S.; Mascola, J. R.; Pope, M.
  3. Aids Research and Human Retroviruses. 2004, AUG; 20(8): 871-884.
  1. 15.   An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS
  2. Wang, S. W.; Bertley, F. M. N.; Kozlowski, P. A.; Herrmann, L.; Manson, K.; Mazzara, G.; Piatak, M.; Johnson, R. P.; Carville, A.; Mansfield, K.; Aldovini, A.
  3. Aids Research and Human Retroviruses. 2004, AUG; 20(8): 846-859.
  1. 16.   Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo
  2. Fitzgerald, W.; Sylwester, A. W.; Grivel, J. C.; Lifson, J. D.; Margolis, L. B.
  3. Journal of Virology. 2004 78(13): 7061-7068.
  1. 17.   Longitudinal follow up of SIVmac pathogenesis in rhesus macaques of Chinese origin: emergence of B cell lymphoma
  2. Ling, B.; Veazey, R. S.; Penedo, C.; Xu, K.; Lifson, J. D.; Marx, P. A.
  3. Journal of Medical Primatology. 2002 31(4-5): 154-163.
  1. 18.   Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus
  2. Kumar, A.; Mukherjee, S.; Shen, J.; Buch, S.; Li, Z.; Adany, I.; Liu, Z. Q.; Zhuge, W.; Piatak, M.; Lifson, J. D.; McClure, H. M.; Narayan, O.
  3. Virology. 2002 301(2): 189-205.
  1. 19.   Maintenance of large numbers of virus-specific CD8(+) T cells in HIV-infected progressors and long-term nonprogressors
  2. Gea-Banacloche, J. C.; Migueles, S. A.; Martino, L.; Shupert, W. L.; McNeil, A. C.; Sabbaghian, M. S.; Ehler, L.; Prussin, C.; Stevens, R.; Lambert, L.; Altman, J.; Hallahan, C. W.; de Quiros, J.; Connors, M.
  3. Journal of Immunology. 2000 165(2): 1082-1092.
  1. 21.   Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen
  2. de Quiros, J.; Shupert, W. L.; McNeil, A. C.; Gea-Banacloche, J. C.; Flanigan, M.; Savage, A.; Martino, L.; Weiskopf, E. E.; Imamichi, H.; Zhang, Y. M.; Adelsburger, J.; Stevens, R.; Murphy, P. M.; Zimmerman, P. A.; Hallahan, C. W.; Davey, R. T.; Connors, M.
  3. Journal of Virology. 2000 74(4): 2023-2028.
  1. 22.   Adoptive cellular immunotherapy: NK cells and bone marrow transplantation
  2. Koh, C. Y.; Welniak, L. A.; Murphy, W. J.
  3. Histology and Histopathology. 2000 15(4): 1201-1210.
  1. 23.   Mechanisms for induction of acquired host immunity by neutrophil peptide defensins
  2. Lillard, J. W.; Boyaka, P. N.; Chertov, O.; Oppenheim, J. J.; McGhee, J. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(2): 651-656.
  1. 24.   Viral Genetic Evolution in Macaques Infected With Molecularly Cloned Simian Immunodeficiency Virus Correlates With the Extent of Persistent Viremia
  2. Hirsch, V. M.; Dapolito, G.; Hahn, A.; Lifson, J.; Montefiori, D.; Brown, C. R.; Goeken, R.
  3. Journal of Virology. 1998 72(8): 6482-6489.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel